Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

$10 Million Investment to Boost InforSense Expansion

Published: Tuesday, October 10, 2006
Last Updated: Tuesday, October 10, 2006
Bookmark and Share
Fleming Family & Partners Private Equity and Imperial Innovations lead strategic investment round.

InforSense Ltd. has announced that the Company has received an investment of $10 million led by two of its largest investors – Fleming Family & Partners Private Equity (FF&P) and Imperial Innovations Group plc (Imperial Innovations).

InforSense will use the investment to continue expanding its global footprint, accelerate product developments and additional application initiatives in both its current and new markets.

"We are pleased to have completed this round of strategic fund-raising and are grateful to FF&P, Imperial Innovations, Elaia Partners, Sitka Health Fund VCT Plc and all our other shareholders for their continued support," said Prof. Yike Guo, Founder and Chief Executive Officer of InforSense.

"With these funds, we are well positioned to increase our growth rate and capitalize on the current success of our business."

David Donnelly, CEO FF&P Private Equity, added, "FF&P Private Equity is delighted to continue to support InforSense."

"The investment is in line with FF&P’s philosophy of backing companies and management teams that are successfully delivering innovative technologies and products to the market. The Company is well placed to enjoy success in the years ahead."

"InforSense has shown tremendous growth in the last twelve months, with a rapidly growing customer base," said Susan Searle, CEO of Imperial Innovations.

"We are delighted to be able to support them as they continue that growth with our largest single investment to date."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

InforSense Partners with U.K.’s Leading Institutions to Combat Alzheimer’s Disease
Translational research solution to help accelerate early diagnosis and personalized medicine treatments.
Wednesday, December 03, 2008
InforSense GenSense Achieves GeneChip-compatible™ Status with the Affymetrix GeneChip® Microarray Platform
Affymetrix has become a member of InforSense’s Open Workflow Partner Network joining over 40 other partners in the program.
Tuesday, August 07, 2007
InforSense® Announces Conference Series
The InforSense Users Conference will provide opportunity to learn how InforSense KDE is being used to facilitate business-critical decision-making across a variety of industries.
Tuesday, November 14, 2006
EU-Funded ARGUGRID Project Adopts InforSense® Integrative Analytics Technology
InforSense to provide integrative analytics environment to support collaborative decision making.
Wednesday, October 04, 2006
InforSense® Appoints David Hadfield as Chief Operating Officer
Former Spotfire executive strengthens InforSense management team.
Tuesday, October 03, 2006
Bayer Selects InforSense for Next Generation Integrative Analytics Infrastructure
InforSense KDE, will provide Bayer with a flexible rapid application development platform to optimize their drug discovery decision-making.
Friday, September 16, 2005
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!